Chimera Investment

CIMNYSEUSD

THESIS ALERT

Email me when the CIM thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$6.77
−$0.22 (−3.15%)Today 1M −24.44%
After hours$6.81+0.59%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$6.99
Prior regular-session close from the quote source.
$6.77–$6.98
Regular-session low and high so far today.
1.9M
Regular-session shares traded · Nov 11, 4:00 PM ET.
Feb 10 projected
Projected for 2027-02-10 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
$6.77–$14.18
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own CIM if Chimera earns investor returns by originating, buying and managing residential mortgage assets and capturing the spread between asset yields and wholesale funding; its value depends on continued access to cheap funding, disciplined credit underwriting.

CIM price history

Latest price$6.77Today−$0.22 (-3.15%)
CIM -23.24%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • Chimera's ability to generate positive net income depends on capturing a persistent net interest/asset spread from originating and holding higher-yielding residential mortgage assets; if asset yields compress or funding costs spike, net income will fall materially.StrengtheningMateriality: High

    net_income rose year-over-year: $126,104,000 (FY2023) -> $176,065,000 (FY2024) -> $230,499,000 (FY2025), showing continued spread capture and profitability. If the spread holds, shareholders get growing earnings and capital stability; if it compresses, the company can lose earnings quickly and be forced to sell or shrink the portfolio.

    Watch: A sustained rise in wholesale funding costs or pullback in repo/secured financing lines from counterparties.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    net_income rose year-over-year: $126,104,000 (FY2023) -> $176,065,000 (FY2024) -> $230,499,000 (FY2025), showing continued spread capture and profitability.

    Open source ↗
  • Chimera can grow earnings by scaling assets through originations and purchases, but that growth is conditional on continued access to wholesale funding and capital markets—loss of that access forces asset reductions and compresses returns.HoldingMateriality: High

    assets increased from $12,928,998,000 (2023) -> $13,116,490,000 (2024) -> $15,808,542,000 (2025), evidence the firm has recently scaled its portfolio. Asset growth without funding access is impossible; sustained asset expansion with stable funding supports higher net income, while funding withdrawal triggers deleveraging and one-time losses.

    Watch: Counterparties reducing committed repo/secured lines or increasing haircuts, forcing the company to sell assets into weak markets.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    assets increased from $12,928,998,000 (2023) -> $13,116,490,000 (2024) -> $15,808,542,000 (2025), evidence the firm has recently scaled its portfolio.

    Open source ↗
  • Chimera's reported profits are volatile and driven in part by mark-to-market and financing timing; operating cash flow can swing sharply and therefore is not yet a reliable source for sustaining dividends or capital returns unless the company stabilizes realized cash.StrengtheningMateriality: Medium

    operating_cash_flow: $213,269,000 (FY2023) -> $205,673,000 (FY2024) -> -$248,879,000 (FY2025), demonstrating large year-to-year swings despite rising net income. Earnings that do not translate into stable operating cash leave the company dependent on external financing to pay dividends or grow assets and raise the risk of forced asset sales in stress.

    Watch: A shift toward holding more liquid or shorter-duration assets or changes in hedging/realization practice that reduce mark-to-market volatility.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    operating_cash_flow: $213,269,000 (FY2023) -> $205,673,000 (FY2024) -> -$248,879,000 (FY2025), demonstrating large year-to-year swings despite rising net income.

    Open source ↗
  • Chimera operates with high leverage (large assets relative to equity), so protecting book equity through underwriting and limited realized losses is essential; meaningful credit losses or mark-to-market losses will erode equity quickly and force deleveraging.StrengtheningMateriality: Medium

    equity has stayed near ~$2.5B while assets rose to $15.8B in 2025, implying a high asset-to-equity ratio and meaningful leverage on the balance sheet. A thin equity cushion relative to asset size increases the probability of forced sales or equity raises if markets turn, diluting existing holders or reducing distributions.

    Watch: Sharp, sustained credit losses on underlying residential loans or securities that lead to large negative net income and book-value declines.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    equity has stayed near ~$2.5B while assets rose to $15.8B in 2025, implying a high asset-to-equity ratio and meaningful leverage.

    Open source ↗
  • Despite asset growth, Chimera's top-line (interest and noninterest income) has been roughly flat, implying either mix shifts or compressing yields; sustaining per-asset returns (not just gross asset scale) is necessary for shareholder value creation.StrengtheningMateriality: Medium

    revenue was roughly flat: $263,363,000 (FY2023) -> $264,676,000 (FY2024) -> $266,419,000 (FY2025) even as assets increased materially over the same period. If revenue per dollar of assets falls, asset growth won't translate into proportional earnings growth — management must preserve asset yields or improve mix to maintain margins.

    Watch: A continuing secular decline in asset yields (e.g., competition in whole-loan buying, tighter RMBS spreads) or higher funding costs that compress net yields.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    revenue was roughly flat: $263,363,000 (FY2023) -> $264,676,000 (FY2024) -> $266,419,000 (FY2025) even as assets increased materially over the same.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Chimera's ability to generate positive net income depends on capturing a persistent net interest/asset spread from originating and holding higher-yielding residential mortgage assets; if asset yields compress or funding costs spike, net income will fall materially. If the spread holds, shareholders get growing earnings and capital stability; if it compresses, the company can lose earnings quickly and be forced to sell or shrink the portfolio.

Chimera can grow earnings by scaling assets through originations and purchases, but that growth is conditional on continued access to wholesale funding and capital markets—loss of that access forces asset reductions and compresses returns. Asset growth without funding access is impossible; sustained asset expansion with stable funding supports higher net income, while funding withdrawal triggers deleveraging and one-time losses.

Chimera's reported profits are volatile and driven in part by mark-to-market and financing timing; operating cash flow can swing sharply and therefore is not yet a reliable source for sustaining dividends or capital returns unless the company stabilizes realized cash. Earnings that do not translate into stable operating cash leave the company dependent on external financing to pay dividends or grow assets and raise the risk of forced asset sales in stress.

Chimera operates with high leverage (large assets relative to equity), so protecting book equity through underwriting and limited realized losses is essential; meaningful credit losses or mark-to-market losses will erode equity quickly and force deleveraging. A thin equity cushion relative to asset size increases the probability of forced sales or equity raises if markets turn, diluting existing holders or reducing distributions.

Despite asset growth, Chimera's top-line (interest and noninterest income) has been roughly flat, implying either mix shifts or compressing yields; sustaining per-asset returns (not just gross asset scale) is necessary for shareholder value creation. If revenue per dollar of assets falls, asset growth won't translate into proportional earnings growth — management must preserve asset yields or improve mix to maintain margins.

All standing thesis claims
Original report summary

Chimera earns investor returns by originating, buying and managing residential mortgage assets and capturing the spread between asset yields and wholesale funding; its value depends on continued access to cheap funding, disciplined credit underwriting.

Evidence assessed Nov 7, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Chimera Investment

Where the evidence on Chimera Investment stands: Holding on the latest evidence (Nov 7, 2026). Of its 5 thesis points, 4 strengthening and 1 holding.

Bull case: what the evidence supports

  • Chimera's ability to generate positive net income depends on capturing a persistent net interest/asset spread from originating and holding higher-yielding residential mortgage assets; if asset yields compress or funding costs spike, net income will fall materially.

    sec.gov ↗

  • Chimera can grow earnings by scaling assets through originations and purchases, but that growth is conditional on continued access to wholesale funding and capital markets—loss of that access forces asset reductions and compresses returns.

    sec.gov ↗

  • Chimera's reported profits are volatile and driven in part by mark-to-market and financing timing; operating cash flow can swing sharply and therefore is not yet a reliable source for sustaining dividends or capital returns unless the company stabilizes realized cash.

    sec.gov ↗

  • Chimera operates with high leverage (large assets relative to equity), so protecting book equity through underwriting and limited realized losses is essential; meaningful credit losses or mark-to-market losses will erode equity quickly and force deleveraging.

    sec.gov ↗

  • Despite asset growth, Chimera's top-line (interest and noninterest income) has been roughly flat, implying either mix shifts or compressing yields; sustaining per-asset returns (not just gross asset scale) is necessary for shareholder value creation.

    sec.gov ↗

Bear case: what would count against it

  • A sustained rise in wholesale funding costs or pullback in repo/secured financing lines from counterparties.

    sec.gov ↗

  • Counterparties reducing committed repo/secured lines or increasing haircuts, forcing the company to sell assets into weak markets.

    sec.gov ↗

  • A shift toward holding more liquid or shorter-duration assets or changes in hedging/realization practice that reduce mark-to-market volatility.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · Chimera Investment

12 mo agonow
Trailing daily price. No thesis break has crossed here, so there is no break base rate to project.

No break has crossed Chimera Investment’s thesis. Its break conditions are checked against every new filing as it lands.

Early warning

The break condition read on the trailing twelve months through Chimera Investment’s latest quarterly report, ahead of the annual figure it is written on.

  • Net loss, trailing 12 months

    Across all companies, this kind of early warning has happened 2,059 times before. Those stocks beat the market by a median of 1% over the next six months, and 35% of them trailed it by 10 points or more.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Regulation FD disclosure.

    Chimera Investment filed an SEC 8-K on 2026-11-05: Regulation FD disclosure. It is a dated development that tests the current thesis.

  2. Mixed
    Reported results of operations (earnings release).

    Chimera Investment filed an SEC 8-K on 2026-11-05: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  3. Mixed
    Regulation FD disclosure.

    Chimera Investment filed an SEC 8-K on 2026-09-17: Regulation FD disclosure. It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • A sustained rise in wholesale funding costs or pullback in repo/secured financing lines from counterparties.
  • Counterparties reducing committed repo/secured lines or increasing haircuts, forcing the company to sell assets into weak markets.
  • A shift toward holding more liquid or shorter-duration assets or changes in hedging/realization practice that reduce mark-to-market volatility.
  • Sharp, sustained credit losses on underlying residential loans or securities that lead to large negative net income and book-value declines.
  • A continuing secular decline in asset yields (e.g., competition in whole-loan buying, tighter RMBS spreads) or higher funding costs that compress net yields.

CIM news

Loading headlines…

Financial statements

CIM income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

CIM: quick answers

When does Chimera Investment (CIM) report earnings next?
Chimera Investment's next results are projected for February 10, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on November 5, 2026. Earnings calendar
What is CIM's short interest?
As of October 30, 2026, 3.7M CIM shares were sold short, 4.39% of its shares outstanding, up 12.3% from the count before. At the stock's average daily volume that is 2.7 days to cover. FINRA publishes the count twice a month. CIM short interest history
Have members of Congress traded CIM?
1 trade in CIM has been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed CIM trade
ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.